Benzylpiperizine compound

Details Benzylpiperizine compound Benzylpiperizine compound

2009-02-04

2011-11-22

Desai, Rita (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S320000

Reexamination Certificate

active

08063223

ABSTRACT:
Disclosed is a benzylpiperizine compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which is useful as a medicinal agent such as an antidepressant agent. (In the formula (1), R1represents a hydrogen atom or a methyl group; R2is a group bound in a p- or m-position relative to a methylene group and represents a chlorine atom bound in a p-position, a bromine atom bound in a p-position, a methyl group bound in a p-position, a chlorine atom bound in a m-position or a bromine atom bound to in a m-position; X represents a methylene or an oxygen atom; and n represents an integer of 1 to 3.)

REFERENCES:
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 5698553 (1997-12-01), Prucher et al.
patent: 6124323 (2000-09-01), Bigge et al.
patent: 6284774 (2001-09-01), Wright et al.
patent: 6787560 (2004-09-01), Kodo et al.
patent: 2003/0191126 (2003-10-01), Kodo et al.
patent: 2005/0065140 (2005-03-01), Kodo et al.
patent: 2007/0219179 (2007-09-01), Suzuki et al.
patent: 9671774 (1996-11-01), None
patent: 2188485 (1997-05-01), None
patent: 0934932 (1999-08-01), None
patent: 2000-500773 (2000-01-01), None
patent: 88/02365 (1988-04-01), None
patent: 97/23216 (1997-07-01), None
patent: 98/08816 (1998-03-01), None
patent: 01/43740 (2001-06-01), None
patent: 02/06231 (2002-01-01), None
patent: 03/053928 (2003-07-01), None
patent: 2004/046124 (2004-06-01), None
patent: 2005/108389 (2005-11-01), None
Y. Sato et al., “Syntheses and Pharmacology of 1-[2-(2-Hydroxyethoxy)-ethyl]-4-p-chlorobenzylpiperidine Hydrochloride (Piclobetol) and the Related Compounds”, Ann. Sankyo Res. Lab., vol. 23, 1971, pp. 104-116.
A.M. Ismaiel et al., “Ketanserin Analogues: The Effect of Structural Modification on 5-HT2 Serotonin Receptor Binding”, J. Med. Chem., vol. 38, 1995, pp. 1196-1202.
Klaus Rehse et al., “Neuropsychotrope Aktivitat dopaminanaloger Piperidin- und Piperazinderivate”, Arch. Pharm. (Weinheim), vol. 312, 1979, pp. 670-681.
Huang et al.; “Guidance for Industry, Drug Interaction Studies—Study Design, Data Analysis, and Implications for Dosing and Labeling”; Sep. 2006; U.S. Food and Drug Administration, pp. 1-52.
Saver et al.; “Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome”; The Journal of Pharmacology and Experimental Therapeutics, vol. 308, No. 2, 2004; pp. 410-418.
Testino Jr., et al.; “High-Throughput Inhibition Screening of Major Human Cytochrome P450 Enzymes Using an in Vitro Cocktail and Liquid Chromatography—Tandem Mass Spectrometry”; Journal of Pharmaceutical and Biomedical Analysis, 30 (2003), pp. 1459-1467.
Di et al.; “Comparison of Cytochrome P450 Inhibition Assays for Drug Discovery Using Human Liver Microsomes With LC-MS, rhCYP450 Isozymes With Fluorescence, and Double Cocktail With LC-MS”; International Journal of Pharmaceutics, 335 (2007); pp. 1-11.

Affiliated with

Also associated with

Rating

Benzylpiperizine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzylpiperizine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylpiperizine compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4263654